Arecor Therapeutics PLC (AREC) — Cash Flow Quality Index
Arecor Therapeutics PLC (AREC) has a Cash Flow Quality Index of -0.33x as of December 2025. Operating cash flow of GBX-1.15 Million is below net income of GBX3.44 Million, suggesting accrual-heavy earnings not yet converted to cash. Also explore balance sheet size of Arecor Therapeutics PLC for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Arecor Therapeutics PLC Cash Flow Quality Index (2025–2025)
Historical Cash Flow Quality Index for Arecor Therapeutics PLC across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check AREC goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Arecor Therapeutics PLC (2025–2025)
Year-by-year earnings quality comparison for Arecor Therapeutics PLC. For live market cap and the full company financial profile, see Arecor Therapeutics PLC market cap and net worth.
| Year | Quality Index | Operating CF (GBX) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | -2.46x | GBX-2.29 Million | GBX932.00K | — |